Re-irradiation for locally recurrent nasopharyngeal carcinoma.

McLean, M; Chow, E; O'Sullivan, B; Munro, A; Leung, P M; Loblaw, D A; Panzarella, T · Radiother Oncol · 1998

case_series · Level IV

Where this comes from

Abstract

Since 1989, 17 patients have undergone re-irradiation for locally recurrent nasopharyngeal cancer (NPC). The dose currently administered externally is 39.6 Gy in 36 fractions (BID) followed by an intracavitary boost (15-20 Gy). Disease persisted in five out of five patients treated palliatively. Eleven of 12 patients treated with curative intent achieved local control.

Medical subject headings